Beta Interferon Tied to Lower Mortality in Relapsing-Onset MS

WEDNESDAY, April 3, 2019 -- For patients with relapsing-onset multiple sclerosis, beta interferon treatment is associated with a lower mortality risk, according to a study published online March 18 in Brain. Elaine Kingwell, Ph.D., from the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news